EUVIMEDEUVIMED entdecken
VergleichsstudieOpen Access · CC BY 4.0

Comparative Analysis of Primary Sarcopenia and End‐Stage Renal Disease–Related Muscle Wasting Using Multi‐Omics Approaches

Daiki Setoyama, Dohyun Han, Jingwen Tian, Ho Yeop Lee, Hyun Suk Shin, Ha Thi Nga, Thi Linh Nguyen, Ji Sun Moon, Hyo Ju Jang, Evonne Kim, Seong-Kyu Choe, Sang Hyeon Ju und 3 weitere

Journal of Cachexia, Sarcopenia and Muscle · 2025

DOI: 10.1002/jcsm.13749 ↗

Kurz gefasst

Vergleichsstudie in der Zeitschrift Journal of Cachexia, Sarcopenia and Muscle, 2025. Verfasst von Daiki Setoyama und 14 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Chemistry and Laboratory Medicine, Kyushu University Hospital, Fukuoka, Japan. Hauptthemen laut MEDLINE: Sarcopenia, Kidney Failure, Chronic, Metabolomics, Muscular Atrophy. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Research Foundation of Korea (NRF), Ministry of Science, ICT, and Future Planning, Korea, Korea Health Industry Development Institute (KHIDI).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Age‐related primary sarcopenia and end‐stage renal disease (ESRD)–related muscle wasting are discrete entities; however, both manifest as a decline in skeletal muscle mass and strength. The etiological pathways differ, with aging factors implicated in sarcopenia and a combination of uremic factors, including haemodialysis, contributing to ESRD‐related muscle wasting. Understanding these molecular nuances is imperative for targeted interventions, and the integration of proteomic and metabolomic data elucidate these intricate processes.

Methods

We generated detailed clinical data and multi‐omics data (plasma proteomics and metabolomics) for 78 participants to characterise sarcopenia ( n = 28; mean age, 72.6 ± 7.0 years) or ESRD ( n = 22; 61.6 ± 5.5 years) compared with controls ( n = 28; 69.3 ± 5.7 years). Muscle mass was measured using bioelectrical impedance analysis and handgrip strength. Five‐times sit‐to‐stand test performance was measured for all participants. Sarcopenia was diagnosed in accordance with the 2019 Consensus Guidelines from the Asian Working Group for Sarcopenia. An abundance of 234 metabolites and 722 protein groups was quantified in all plasma samples using liquid chromatography with tandem mass spectrometry.

Results

Muscle mass, handgrip strength and lower limb muscle function significantly lower in the sarcopenia group and the ESRD group compared with those in the control group. Metabolomics revealed altered metabolites, highlighting exclusive differences in ESRD‐related muscle wasting. Metabolite set enrichment analysis revealed the involvement of numerous metabolic intermediates associated with urea cycle, amino acid metabolism and nucleic acid metabolism. Catecholamines, including epinephrine, dopamine and serotonin, are significantly elevated in the plasma of patients within the ESRD group. Proteomics data exhibited a clearer distinction among the three groups compared with the metabolomics data, particularly in distinguishing the control group from the sarcopenia group. The ciliary neurotrophic factor receptor was top‐ranked in terms of the variable importance of projection scores. Plasma AHNAK protein levels was higher in the sarcopenia group but was lower in the ESRD group. Proteomic set enrichment analysis revealed enrichment of several pathways related to sarcopenia, such as hemopexin, defence response and cell differentiation, in sarcopenia group. Multi‐omic integration analysis revealed associations between relevant metabolites, including catecholamines, and a group of annotated proteins in extracellular exosomes.

Conclusions

We identified distinct multi‐omic signatures in individuals with ESRD or sarcopenia, providing new insights into the mechanisms underlying ESRD‐related muscle wasting, which differ from primary sarcopenia. These findings may support interventions for context‐dependent muscle loss and contribute to the development of targeted treatments and preventive strategies for muscle wasting.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

SarcopeniaKidney Failure, ChronicMetabolomicsMuscular AtrophyHumansMaleAgedFemaleMiddle AgedProteomicsMuscle, SkeletalMultiomics

Stichwörter der Autor:innen

end‐stage renal diseasemetabolomicsmulti‐omicsproteomicssarcopenia

Autor:innen und Institutionen

  • Department of Clinical Chemistry and Laboratory Medicine, Kyushu University Hospital, Fukuoka, Japan.
  • Proteomics Core Facility, Seoul National University Hospital Biomedical Research Institute, Seoul, South Korea.
  • Laboratory of Endocrinology and Immune System, Chungnam National University School of Medicine, Daejeon, South Korea.
  • Department of Medical Science, Chungnam National University School of Medicine, Daejeon, South Korea.
  • Department of Biomedical Sciences, BK21 FOUR Biomedical Science Program, Seoul National University College of Medicine, Seoul, South Korea.
  • Department of Medicine, Graduate School, Wonkwang University, Iksan, South Korea.

ORCID-Profile: Hyon-Seung Yi

Förderung

  • National Research Foundation of Korea (NRF)
  • Ministry of Science, ICT, and Future Planning, Korea
  • Korea Health Industry Development Institute (KHIDI)
  • Ministry of Health and Welfare, Republic of Korea
  • Korea government (MSIT)

Zitieren

APA

Setoyama, D., Han, D., Tian, J., Lee, H. Y., Shin, H. S., Nga, H. T., Nguyen, T. L., Moon, J. S., Jang, H. J., Kim, E., Choe, S. K., Ju, S. H., Choi, D. E., Kwon, O., & Yi, H. S. (2025). Comparative Analysis of Primary Sarcopenia and End‐Stage Renal Disease–Related Muscle Wasting Using Multi‐Omics Approaches. Journal of Cachexia, Sarcopenia and Muscle. https://doi.org/10.1002/jcsm.13749

Vancouver

Setoyama D, Han D, Tian J, Lee HY, Shin HS, Nga HT, et al. Comparative Analysis of Primary Sarcopenia and End‐Stage Renal Disease–Related Muscle Wasting Using Multi‐Omics Approaches. Journal of Cachexia, Sarcopenia and Muscle. 2025. doi:10.1002/jcsm.13749

BibTeX
@article{Setoyama2025,
  author = {Setoyama, Daiki and Han, Dohyun and Tian, Jingwen and Lee, Ho Yeop and Shin, Hyun Suk and Nga, Ha Thi and Nguyen, Thi Linh and Moon, Ji Sun and Jang, Hyo Ju and Kim, Evonne and Choe, Seong-Kyu and Ju, Sang Hyeon and Choi, Dae Eun and Kwon, Obin and Yi, Hyon-Seung},
  title = {Comparative Analysis of Primary Sarcopenia and End‐Stage Renal Disease–Related Muscle Wasting Using Multi‐Omics Approaches},
  journal = {Journal of Cachexia, Sarcopenia and Muscle},
  year = {2025},
  doi = {10.1002/jcsm.13749}
}
Kostenlos starten →